Literature DB >> 6156998

Monospecific antibody to the haemagglutinin of measles virus.

D E McFarlin, W J Bellini, E S Mingioli, T N Behar, A Trudgett.   

Abstract

A hybrid between a murine myeloma cell line and spleen cells from a mouse immunized with measles has been produced. Two stable clones produce antibody with identical immunochemical and biological properties. This antibody reacts with the 76,000 mol. wt. protein present in the lysates and on the surface of cells persistently infected with measles. It exhibits HAI and neutralizing activity.

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6156998     DOI： 10.1099/0022-1317-48-2-425

Source DB:  PubMed          Journal:  J Gen Virol        ISSN： 0022-1317            Impact factor:   3.891


  15 in total

1.  Characteristics of a cetacean morbillivirus isolated from a porpoise (Phocoena phocoena).

Authors:  M J Welsh; C Lyons; A Trudgett; B K Rima; S J McCullough; C Orvell
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

2.  Immunosorbent assay based on recombinant hemagglutinin protein produced in a high-efficiency mammalian expression system for surveillance of measles immunity.

Authors:  F Bouche; W Ammerlaan; F Berthet; S Houard; F Schneider; C P Muller
Journal:  J Clin Microbiol       Date:  1998-03       Impact factor: 5.948

3.  V domain of human SLAM (CDw150) is essential for its function as a measles virus receptor.

Authors:  N Ono; H Tatsuo; K Tanaka; H Minagawa; Y Yanagi
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

4.  Biosynthesis of measles virus hemagglutinin in persistently infected cells.

Authors:  W J Bellini; G D Silver; D E McFarlin
Journal:  Arch Virol       Date:  1983       Impact factor: 2.574

5.  Five measles virus antigens demonstrated by use of mouse hybridoma antibodies in productively infected tissue culture cells.

Authors:  E Norrby; S N Chen; T Togashi; H Shesberadaran; K P Johnson
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

6.  Development of antibody to measles virus polypeptides during complicated and uncomplicated measles virus infections.

Authors:  M Graves; D E Griffin; R T Johnson; R L Hirsch; I L de Soriano; S Roedenbeck; A Vaisberg
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

7.  Immune reactivity of the purified hemagglutinin of measles virus.

Authors:  W J Bellini; D E McFarlin; G D Silver; E S Mingioli; H F McFarland
Journal:  Infect Immun       Date:  1981-06       Impact factor: 3.441

8.  Idiotypes and biological activity of murine monoclonal antibodies against the hemagglutinin of measles virus.

Authors:  J Gheuens; D E McFarlin; K W Rammohan; W J Bellini
Journal:  Infect Immun       Date:  1981-10       Impact factor: 3.441

9.  SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein.

Authors:  Koji Hashimoto; Nobuyuki Ono; Hironobu Tatsuo; Hiroko Minagawa; Makoto Takeda; Kaoru Takeuchi; Yusuke Yanagi
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

10.  Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles.

Authors:  K C McCullough; R Butcher
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.